Agoracom Blog Home

Archive for the ‘HPQ-Silicon Resources Inc.’ Category

HPQ Silicon Lands First Commercial Battery Order—Silicon Anodes Break Into European Drone Market

Posted by Alavaro Coronel at 5:51 PM on Wednesday, April 22nd, 2026

When a company moves from lab validation to a paid commercial order, something fundamental has shifted. HPQ Silicon $HPQ / $HPQFF and its partner Novacium have secured their first commercial battery order from a European drone manufacturer, marking a clear transition from development to revenue. This is not a test or pilot. It is a paid order using next-generation silicon-based batteries that recently delivered over 7,000 mAh in testing, offering higher capacity than traditional graphite batteries.

The order signals a move from promising technology to real-world use. Backed by up to $3 million in Canadian federal funding, HPQ is advancing toward commercial scale with batteries designed to deliver higher energy capacity and longer flight times, while supporting deployment in standardized battery pack formats. The batteries are certified for global transport and have demonstrated strong durability through repeated charge cycles, reinforcing readiness for real-world deployment.

WHAT YOU NEED TO KNOW

Commercial Milestone: First paid commercial battery order secured, marking the shift from R&D to revenue generation

High Performance: Batteries delivered over 7,000 mAh in April 2026 testing, placing them among top performers in their category

Drop-In Solution: Designed to work within existing drone systems, allowing immediate performance improvements without redesign

Proven Durability: Maintains strong performance through repeated use, addressing a key challenge for silicon battery adoption

Global Ready: Certified for international shipping, enabling deployment across multiple markets

Government Backing: Up to $3 million federal funding supports production scale-up and highlights strategic importance

STRATEGIC IMPLICATIONS

For years, silicon-based batteries have promised higher performance but struggled to translate into real-world products. Many technologies achieved strong lab results but failed under repeated use or required costly redesigns. That is why graphite batteries have remained dominant despite lower performance.

HPQ’s approach changes that. By integrating silicon-based materials into formats that work with existing manufacturing and systems, the company removes a major barrier to adoption. Customers do not need to redesign their products. They can upgrade performance immediately.

That advantage is already being demonstrated. The European drone manufacturer did not need to modify its systems. It was able to adopt the new battery packs and gain longer flight time right away. This is the difference between a technology concept and a usable product.

Demand for longer flight time is increasing across commercial, industrial, and defense drone markets, while traditional battery solutions are approaching their limits. Technologies that can deliver better performance without added complexity are well positioned to capture that demand.

Government support reinforces this direction. Federal funding for production scale-up signals growing strategic importance, while also supporting the path toward larger-scale manufacturing.

“Projects like HPQ Silicon’s strengthen Canada’s ability to manufacture components for high-performance batteries, and are creating a world-class battery ecosystem.” – The Honourable Tim Hodgson, Minister of Energy and Natural Resources

WORDS FROM THE CEO

“We went from discussions to delivering next-generation batteries in about a month. That’s what happens when the product fits into existing systems. We’re not asking customers to redesign anything—we’re giving them more energy in the same format. And this order is commercial. It’s paid. We’ve moved from ‘will it work’ to ‘we have delivered.’” – Bernard Tourillon

INVESTOR TAKEAWAY

HPQ Silicon has reached a key inflection point. The company now has global shipping certification, government support for scaling production, and its first commercial battery order, all within a short timeframe.

Its battery solutions are designed for immediate use across multiple markets, including Europe and North America, without requiring major system changes. As production expands, the company is positioning itself to meet increasing demand for higher-performance energy storage.

Performance is no longer theoretical. The batteries have demonstrated strong capacity and durability in testing and are now being used in a commercial application.

This marks the shift from a development story to a commercialization story, with early revenue, validated performance, and a clear path toward scale.

 

HPQ Silicon’s 7,000 mAh Breakthrough – Could This Be The Battery Industry’s Four-Minute Mile?

Posted by Alavaro Coronel at 5:55 PM on Wednesday, April 15th, 2026

When a company reports results that suggest it can do what others have not widely demonstrated, markets pay attention. HPQ Silicon Inc.’s $HPQ / $HPQFF GEN4 21700 cells just crossed 7,030 mAh at 0.55V lower cutoff – a level that, to the company’s knowledge, has not been widely reported in publicly available data for an industrial-format cell under comparable conditions.

This reflects more than just capacity, including the ability to cycle under extended voltage conditions in testing that would typically result in significant degradation in conventional lithium-ion batteries, with less than 2% degradation over 70 cycles. HPQ Silicon, backed by up to $3 million in Canadian federal funding and exclusive North American rights to Novacium’s silicon-anode technology, is now advancing toward commercialization, with the CEO stating the company is in discussions with drone manufacturers, military groups, and e-mobility partners.

WHAT YOU NEED TO KNOW

Voltage Breakthrough:
0.55V cutoff may provide approximately 5% more usable energy based on internal estimates, typically inaccessible in lithium-ion cells operated at conventional cutoffs.

Cycle Stability:
Less than 2% degradation over 70 cycles at extended voltage — described by the company as a performance level not commonly observed under similar conditions.

Production Pathway:
HPQ is advancing a production plan with capacity in the range of approximately 600,000 21700 cells annually, with discussions underway with drone, military radio, and e-bike manufacturers.

Government Backing:
Up to $3M federal grant from Natural Resources Canada supports HPQ’s first battery production facility in Canada and is intended to help strengthen domestic supply chains.

Federal Support:
Canada’s Minister of Energy and Natural Resources has previously stated: “Projects like HPQ Silicon’s strengthen Canada’s ability to manufacture components for high-performance batteries and are creating a world-class battery ecosystem.”

STRATEGIC IMPLICATIONS

The battery industry faces significant performance constraints. Conventional graphite anodes in 21700 cells are commonly reported in the ~5,000 mAh range. Silicon-enhanced cells from leading developers are reported in the ~6,000–6,500 mAh range. But there’s a second problem that receives less attention: every lithium-ion battery carries energy below the commonly used ~2.5V cutoff. Go below that threshold with graphite, and you risk transforming a rechargeable battery into a single-use cell because the material can degrade rapidly. The industry has largely lived with this constraint for years.

HPQ’s GEN4 silicon-anode material is designed to operate in this lower-voltage region. By cycling down to 0.55V with under 2% degradation over 70 full charge-discharge cycles in testing, the company reports that it has accessed energy that is typically not utilized. The company states that internal calculations indicate this could translate to about 5% more runtime from the same physical battery under comparable conditions. For a military drone operating at the edge of its range, this could be meaningful for performance and runtime. For an electric bike commuter, it could mean additional range without adding weight. For defense contractors, it represents a potential alternative high-performance option in a segment where performance differentiation is important.

The timing is notable. Canada has announced large-scale spending programs targeting domestic industrial capacity and clean-energy infrastructure. The U.S. is reshoring critical supply chains. Europe is seeking additional non-Asian battery materials. HPQ holds exclusive North American rights to commercialize its GEN3 and GEN4 silicon-based anode materials with Novacium. The company is focusing on applications where performance, supply-chain security, and operational advantage can support premium positioning: drones, military radios, handheld power tools, and stationary energy storage.

CEO Bernard Tourillon:

“What we’ve demonstrated isn’t just higher capacity — it’s a new operating mode for our cells under test conditions. We can access energy that conventional batteries typically leave on the table, and we’re doing it with cycle stability that holds up over dozens of charge-discharge cycles. The phone’s ringing. We’re in discussions with drone manufacturers, defense departments, and niche mobility players who are evaluating exactly what we’ve built. We’ve gone from ‘Can it work?’ to ‘How fast can you scale?'”

INVESTOR TAKEAWAY

HPQ Silicon has reported a significant test milestone. The 7,030 mAh result at extended voltage is not presented as a one-off curiosity — it is described by the company as a performance level not widely reported in publicly available data for industrial 21700 cells under comparable conditions.

These results are based on internal testing and have not been independently verified, and may not be representative of commercial performance. Federal funding helps support the path toward scaled production. Early interest and testing discussions in high-value verticals indicate potential commercial pathways.

The company’s exclusive North American license with Novacium and domestic production strategy align with government priorities around supply-chain security and critical materials independence. With an initial production pathway defined and a stated roadmap toward commercialization, HPQ is positioning its battery initiative as a developing commercialization story entering its next phase.

HPQ Silicon’s GEN4 Battery Performance – The Supercar Engine Moment For Lithium-Ion Cells

Posted by Alavaro Coronel at 4:30 PM on Wednesday, April 8th, 2026

When a company demonstrates battery performance that only a small number of others have reached, it suggests progress beyond early research and toward real-world applications. HPQ’s latest GEN4 battery cells deliver more than 6,600 mAh on average, with a peak of 6,696 mAh, placing them among the highest-performing cells of this size ever reported. These are fully built 21700-format cells, rather than lab-scale test samples.

HPQ, working with its R&D partner Novacium, is now operating within this upper tier of battery performance globally. It also has support of up to $3 million from the Canadian government to help scale production. The next step is translating performance into commercial opportunities.

WHAT YOU NEED TO KNOW

Top-Level Results: These batteries reach performance levels achieved by only a small number of companies worldwide.

Built For Real Use: The cells are made in a standard commercial format, showing compatibility with existing battery manufacturing processes.

Driven By Customers: The move to larger battery sizes reflects what buyers are asking for.

Focused Market Entry: Early use cases include drones, military equipment, and specialized electronics where performance matters most.

Government Backing: Federal funding is supporting commercialization efforts.

WHY THIS MATTERS

Most batteries today still depend on materials and supply chains based in Asia. Higher-performance batteries in this category are limited and often not available in large quantities.

HPQ’s silicon-based material aims to address this by offering higher performance in a format that works with existing manufacturing processes. The company is focusing on markets where longer battery life or lighter weight directly creates value.

At the same time, governments are pushing to build local battery supply chains. HPQ is positioned within this trend, with funding support and growing interest from potential customers in sectors like drones and defense.

CEO COMMENTARY  

“Reaching an average above 6,500 mAh, with a peak of 6,696 mAh, using a material that has not yet been fully optimized, confirms we have an industrially viable, high-performance solution advancing within our commercialization pathway. To our knowledge, this level of capacity ranks among the highest reported for an industrial 21700-format cell.”said Bernard Tourillon, President and CEO of HPQ Silicon. 

INVESTOR TAKEAWAY

HPQ is moving beyond early testing. Previous versions already showed strong performance over time, and this latest version pushes capacity into a range achieved by only a few global players.

For investors, this strengthens HPQ’s position in ongoing discussions with potential customers. It also shows a clearer path from development to revenue, supported by government funding and a plan to scale production.

There are still risks around securing customers and funding expansion, but the company now has a strong product, backing, and a focused strategy.

HPQ Closes $3M Financing And Resets Novacium Structure As Battery And Hydrogen Technologies Move Toward Commercialization

Posted by Alavaro Coronel at 5:43 PM on Thursday, March 5th, 2026

When a development-stage technology company raises new capital while simplifying the governance structure of a key technology partner, it can signal a shift in how management plans to advance its programs. In this case, that transition is defined by HPQ Silicon closing a fully subscribed $3 million non-brokered private placement, while simultaneously finalizing its increased ownership and revised governance framework at Novacium SAS.

HPQ Silicon, a Québec-based advanced materials and process development company, intends to use the capital to support general working capital, advance a matching $3 million NRCan-supported silicon-based battery materials program, and continue development of its hydrogen technologies, while the Novacium restructuring is designed to support access to targeted funding programs in France and Europe. Together, these developments provide the company with additional capital and a simplified governance structure as it continues advancing its technology platforms.

WHAT YOU NEED TO KNOW

  • $3M Financing Closed: HPQ raised $3M CAD byissuing approximately 18.18 million units.
  • NRCan Program Advancement: Participation in the NRCan-supported silicon battery materials program requires HPQ to incur eligible costs before reimbursement.
  • Novacium Governance Update: Ownership in Novacium increased to 36.8%, while HPQ converted its Category P priority share into common shares, simplifying governance.

STRATEGIC IMPLICATIONS

Energy transition technologies and advanced materials development often require significant capital and long development timelines. As electrification expands and demand grows for higher-performance batteries and alternative energy systems, companies are exploring new materials and delivery technologies designed to improve performance and reliability.

Through Novacium, HPQ is advancing silicon-based anode materials. According to previously reported testing results released by the company, Novacium’s GEN3 silicon-based anode batteries demonstrated more than 1,000 charge cycles and approximately a 30% cumulative energy gain compared with graphite-based benchmark batteries under reported testing conditions.

Novacium is also advancing METAGENE, a hydrogen technology platform focused on enabling on-demand energy generation. HPQ holds exclusive North American rights related to that technology through its partnership structure with Novacium.

During the interview, management stated it believes the company now has clearer visibility on potential commercialization pathways, including specialized battery applications, partner-financed fumed silica production facilities, and hydrogen deployments aligned with remote energy needs and critical-minerals development.

The $3M financing, completed with an investor outside Canada, is intended to provide working capital and allow the company to continue advancing its development programs while pursuing potential partnerships, government support, and commercial opportunities.

CEO BERNARD TOURILLON

“We’ve reached the point where the fly-by-the-seat-of-your-pants structure just doesn’t work anymore. We believe we know where our revenues are going to come from, and we needed to stop thinking quarter to quarter and fund the plan.”

INVESTOR TAKEAWAY

For investors, the interview outlines management’s view that the financing and Novacium governance changes provide additional capital and structural clarity as HPQ advances its technology platforms.

The private placement supports continued work on the NRCan-supported silicon-anode battery materials program, while also supporting hydrogen technology development and general corporate initiatives.

At the same time, Novacium’s simplified governance structure may help align the company with potential European energy and innovation funding programs, while HPQ’s ownership position in Novacium increases to 36.8%.

Management also indicated that fumed silica commercialization may be pursued through partner-financed plant structures, which could allow HPQ to focus its capital on battery materials and hydrogen technologies.

Overall, management believes the company is positioned to continue advancing its technologies as it works toward potential commercialization opportunities across its battery materials and hydrogen platforms.

HPQ Marks First Paid Fumed Silica Order With 50 kg Pilot Batch

Posted by Alavaro Coronel at 7:56 AM on Friday, February 20th, 2026

WHAT YOU NEED TO KNOW?

  • Paid Purchase Order: Management confirms the 50 kg fumed silica order is paid, with material produced and shipment logistics underway.
  • Pilot Plant Function: The facility is performing its intended role — demonstrating scalable material production rather than prioritizing immediate revenue generation.
  • Application Objectives: Management indicates that internal work and independent laboratory testing support that the material meets the goals for the intended application.
  • Due Diligence Relevance: The batch is framed as a meaningful component of the technical due diligence process tied to a potential joint venture.
  • Operational Data: Pilot plant runs are now informing more detailed assumptions, including practical considerations such as shifts, staffing, and location-dependent cost factors.
  • Market Signaling: Management notes that milestones such as paid production runs may influence how other parties evaluate ongoing discussions.

When a pilot plant progresses from demonstrating production capability to fulfilling a paid purchase order, the discussion naturally shifts from technical feasibility to real operating performance. HPQ Silicon management confirms the company has received a purchase order for 50 kilograms of fumed silica, has produced the material, and is now finalizing shipment logistics as the counterparty determines where the batch will be sent. Management explicitly states the order is paid, while underscoring an important distinction for investors: pilot plants are designed to validate commercial-scale production and generate operating data, not serve as near-term profit centers. The batch is described as part of the technical due diligence process associated with a potential joint venture, with management noting that successful material production is a necessary condition for advancing discussions. Internal testing and independent laboratory testing are described as supporting that the material meets the objectives required for the intended application.

STRATEGIC IMPLICATIONS

Management emphasizes that pilot plants are not structured as profit-driven operations. Their purpose is to demonstrate that commercially valuable material can be produced and to provide the data required for designing larger-scale facilities. The discussion highlights that once systems are functioning, producing a single larger batch becomes more operationally efficient than multiple small runs. Management also indicates that a significant portion of current activity is concentrated on the joint venture process, describing both HPQ Silicon and its technical partner as heavily engaged in technical evaluation, operational analysis, and commercial discussions.

INVESTOR TAKEAWAY

The significance of the paid 50 kg batch is primarily technical and strategic rather than financial. The milestone reflects pilot plant validation, supports customer-side application testing, and contributes to the refinement of detailed operating assumptions required for potential commercial expansion. As described by management, the project remains positioned within an active due-diligence phase rather than a finalized commercial rollout.

HPQ Silicon’s Fumed Silica Joint Venture Mirrors The Desktop Revolution – Innovation Disrupts A Century-Old Industry

Posted by Alavaro Coronel at 8:28 AM on Friday, February 13th, 2026

When a company crosses the line from technical validation to signed commercial agreements with secured financing, markets take notice. HPQ Silicon has signed a non-binding memorandum of understanding with a strategic industrial partner to form a joint venture that would build and operate a 1,000-tonne-per-year commercial fumed silica plant valued at US$20.0 million. 

The partner has already secured project financing. This follows January 30, 2026 independent verification confirming HPQ’s pilot-scale reactor produces commercial-grade “150” fumed silica. With the technical risk answered, now came the commercial deployment question which seems to now be answered with one breaking headline:

HPQ Signs Joint Venture MOU for a Commercial Fumed Silica Plant with Strategic Partner

WHAT YOU NEED TO KNOW

  • Financing Secured: The strategic partner has already locked in project funding for the US$20.0 million commercial plant, eliminating a major execution risk.

  • Grade 150 Verified: Independent testing on January 30, 2026 confirmed HPQ’s pilot reactor produces commercial-grade fumed silica meeting industry-standard 150 m²/g surface area and required viscosity specifications.

  • Toxic-Free Process: HPQ’s plasma-based reactor eliminates silicon tetrachloride and hydrogen chloride – the hazardous chemicals that forced half the industry to relocate to China.

  • Dramatic Cost Advantage: The single-step process consumes ~ 87% less energy and produces ~ 84% fewer emissions than conventional multi-step manufacturing while enabling on-site production.

  • Q2 2026 Target: Definitive agreements are expected by the end of second quarter 2026, with plant delivery anticipated within 12 months of joint venture formation.

Commercial Structure and Strategic Intent

The joint venture is expected to own and operate the facility, with production sold under an offtake arrangement to the strategic partner (terms and conditions yet to be agreed upon). Under the contemplated structure, HSPI (HPQ’s wholly owned subsidiarywould receive recurring royalties on each kilogram of fumed silica sold, (price/kg not yet agreed upon), providing HSPI and HPQ with long-term exposure to operating revenues while maintaining a capital-efficient profile.

This structure is intended to align HSPI and HPQ’s interests with long-term production performance while creating a platform that can be replicated across multiple sites as demand grows. Management views this approach as a scalable pathway to commercial deployment rather than a single, stand-alone facility.

HPQ does caution with “While the MOU reflects a shared intent to proceed, there can be no assurance that a joint venture will ultimately be formed, that it will be completed within the anticipated timeline, or that it will prove commercially viable.”

STRATEGIC IMPLICATIONS

For decades, fumed silica manufacturing has relied on a toxic, multi-step process that converts metallurgical silicon into silicon tetrachloride, then hydrolyzes it at extreme temperatures while generating massive volumes of hydrogen chloride waste and CO₂ emissions. Environmental regulations pushed at least half of global production to China, creating supply chain vulnerabilities and locking manufacturers into centralized production models with complex logistics. What incumbents failed to achieve was elimination of the chemical inputs entirely – the breakthrough that enables decentralized, on-site manufacturing.

HPQ’s plasma-based Fumed Silica Reactor uses quartz as the sole feedstock and produces zero hazardous by-products. The November 2025 pilot-scale results demonstrated up to 191 m²/g surface area with 99.8% purity, and the January 2026 verification confirmed commercial-grade “150” specifications – the benchmark the entire industry had been waiting for. 

This positions HPQ to redefine how manufacturers access a US$2.57 billion global market dominated by chemical giants who cannot easily replicate a process they don’t control.

The timing aligns with reshoring mandates and supply chain security concerns. Industries reliant on fumed silica increasingly seek alternatives to centralized Chinese production. HPQ offers localized manufacturing at or near the point of use, fundamentally restructuring logistics while delivering superior unit economics through dramatically lower energy consumption and zero waste management costs. The joint venture partner has already secured financing and defined market requirements. This is validation from an industrial buyer with capital committed.

CEO BERNARD TOURILLON:

“This is the demonstration of all the work we’ve done paying off. We’ve demolished the barriers to entry to make fumed silica. Now we’re building something solid, step by step. The fumed silica business is becoming a very strong standalone thing.”

INVESTOR TAKEAWAY

HPQ Silicon has transitioned from technical validation to signed commercial agreements with secured financing. The January 30, 2026 independent verification removed the scaling question, and the February 12, 2026 joint venture MOU answers the commercialization question. With a strategic partner who has capital committed and defined market requirements, 

HPQ enters the revenue stage with a technology that eliminates toxic chemicals, dramatically reduces costs, and enables reshoring advantages that legacy producers cannot match without abandoning their entire infrastructure. 

For investors seeking exposure to advanced materials disruption with tangible proof points and near-term commercial deployment, this marks the inflection from development to deployment.

HPQ Silicon Increases Novacium Stake to 36.8%

Posted by Alavaro Coronel at 11:00 AM on Thursday, February 5th, 2026

In a recent long-form video interview with AGORACOM (see link at the end of this article), HPQ Silicon CEO Bernard Tourillon addressed pointed shareholder questions about the company’s decision to acquire an additional 8.4% equity stake in French technology partner Novacium SAS.

The transaction, completed entirely through share issuance, increases HPQ’s ownership from 28.4% to 36.8% while maintaining Novacium’s valuation at the same level as the previous year—a point that drew immediate scrutiny from investors.

The all-share deal is valued at approximately C$4 million (EUR 2.5 million) and results in 5.2% dilution to existing HPQ shareholders through the issuance of 22.4 million new common shares. Management defended the transaction as strategic positioning ahead of what Tourillon characterized as imminent commercialization across Novacium’s battery materials, hydrogen generation, and waste-to-energy technology platforms.

 

AGORACOM – Beyond The Mic Feature Article
February 5, 2026

Transaction Structure and Terms

The equity increase was structured as a share-for-ownership exchange between HPQ and three Novacium shareholders:

  • Ownership change: HPQ stake increases from 28.4% to 36.8%
  • Equity acquired: 8.4 percentage point increase
  • Consideration: 22,407,916 HPQ common shares
  • Deemed price: C$0.18 per share
  • Implied valuation: EUR 30 million (≈ C$50 million)
  • Dilution impact: 5.2% to HPQ shareholders

Notably, the EUR 30 million valuation matches the valuation used in HPQ’s prior Novacium ownership increase in early 2025—despite management citing meaningful technology advancement and de-risking over the past 12 months.

 

Strategic Rationale: Why Now?

When pressed on timing and strategic intent, Tourillon outlined several interconnected objectives.

Preventing Future Dilution

Management expressed concern that as Novacium approaches commercialization, it could seek outside investors—potentially reducing HPQ’s participation in future revenues.

“Maybe Novacium would have started to take a look at outside investors and we would end up having less of the future revenue stake,” Tourillon said.

Global Value Participation

While HPQ holds exclusive North American commercialization rights, its exposure to international revenue streams is limited. Increasing its equity stake expands HPQ’s participation in potential global licensing, royalty, and partnership revenues outside its licensed territory.

Founder Alignment

By converting Novacium shareholders into HPQ equity holders, the transaction aligns founder incentives with HPQ’s success rather than maximizing Novacium’s standalone valuation.

Tourillon described the three selling shareholders as the “brainiacs behind a lot of the projects,” comparing the structure to equity-based retention strategies for critical technical talent.

Enabling European Independence

At 36.8% ownership, HPQ remains below the 50% control threshold that would classify Novacium as foreign-controlled—potentially disqualifying it from European government grants and non-dilutive financing programs.

This structure allows Novacium to pursue EU funding while HPQ retains significant economic exposure.

 

The Valuation Debate

Shareholder criticism focused on two primary issues:

  1. The EUR 30 million valuation
  2. The absence of an independent third-party valuation

Management’s Defense

Tourillon acknowledged HPQ did not commission a formal external valuation, citing costs of approximately $250,000–$300,000.

Instead, management relied on:

  • Internal comparative analysis of publicly traded battery materials companies
  • Informal consultations with financial industry contacts
  • Assessment that Novacium’s technologies have advanced materially since the 2025 transaction

“I think that Novacium is worth a heck of a lot more than the transaction we did, but we were able to negotiate that transaction with the founders because of our relationship over the years,” Tourillon said, describing the deal as a “hometown discount.”

Comparable Company Context

Management pointed to significantly higher valuations for companies developing comparable battery and hydrogen technologies—particularly those approaching commercial revenue generation.

Tourillon noted that firms preparing to sell batteries or cells to government and private customers typically command valuations well above Novacium’s implied valuation.

Risk Consideration

Despite management’s confidence, Novacium’s platforms remain in development. Commercialization timelines depend on market adoption, partner execution, and scalability—introducing inherent uncertainty.

 

Intellectual Property and Licensing Protections

A key shareholder concern focused on how HPQ protects its economic interests in Novacium-developed intellectual property, particularly when technologies originate with individual founders.

Binding Licensing Agreements

Tourillon confirmed the existence of formal, enforceable agreements granting HPQ exclusive North American commercialization rights for all Novacium technologies.

Key protections include:

  • Comprehensive licensing agreements covering all Novacium platforms
  • Battery-related patents filed directly in HPQ’s name (developed under contract)
  • License terms embedded into patent documentation as technologies mature
  • Disclosure of agreements in HPQ financial statements and institutional data rooms

“There is a very clear patent license agreement between Novacium and HPQ,” Tourillon said.

These arrangements prevent Novacium from licensing HPQ’s North American territory to third parties.

 

Battery Development Update: Drone Applications Emerge

Beyond transaction mechanics, Tourillon provided insight into Novacium’s battery progress—helping explain management’s near-term confidence.

Application-Specific Strategy

Rather than pursuing a universal battery solution, Novacium is developing application-specific batteries that can be adapted with minimal modification based on customer needs.

Drone Manufacturer Interest

Drone batteries have emerged as a likely first commercial application, driven by direct manufacturer demand.

“Drone manufacturers are actually probably the ones more interested,” Tourillon said, noting many prefer to focus on building drones rather than sourcing batteries from multiple suppliers.

Customer Feedback

Tourillon reported that feedback from potential customers has focused on pricing, not performance—indicating no technical deficiencies or competitiveness concerns.

 

Corporate Structure Changes: Enabling European Growth

The transaction coincides with structural changes designed to give Novacium greater operational independence in Europe.

New Branding and Market Presence

Novacium recently launched a redesigned website (novacium.com) to establish a standalone identity. This enables:

  • Independent European marketing and business development
  • Direct engagement with European investors and partners
  • Eligibility for government and quasi-government funding
  • Communication of technical milestones without HPQ public-company disclosure constraints

Strategic Logic

Tourillon described HPQ’s previous communication control as a “straitjacket” that limited Novacium’s European growth.

“It’s to our advantage that they become better known without the constraint of HPQ as a publicly traded company,” he said.

Increased Novacium visibility could also drive investor interest in HPQ as the only public-market proxy for the technology.

 

Share Distribution and Liquidity Considerations

Shareholders noted that the C$4 million in HPQ shares were issued to individual Novacium shareholders rather than Novacium’s treasury—raising questions about growth capital versus founder liquidity.

Management’s Characterization

Tourillon acknowledged this as “not an unfair assessment”, framing it as a strategic rotation rather than a liquidity exit.

The structure:

  • Converts founders’ interests from Novacium equity to HPQ equity
  • Provides partial liquidity while maintaining long-term alignment
  • Functions similarly to equity compensation for key talent
  • Exposes founders to the same share-price risk as HPQ shareholders

Post-Hold Period Trading

Shares are subject to a standard four-month regulatory hold period, after which they may be traded. Tourillon acknowledged the risk of selling pressure but noted recipients understand that aggressive selling would be self-defeating.

 

Near-Term Outlook and Pipeline

While constrained by regulatory and third-party confidentiality, Tourillon indicated multiple developments are progressing.

Expected Timeframes

Management expects at least two of Novacium’s four technology platforms to “really take off” within 12 months, with the remainder following in 18–24 months, including:

  • Battery materials (notably drone applications)
  • Hydrogen on-demand systems
  • Waste-to-energy processes

Communication Constraints

“There’s a lot of great moving parts moving forward, and a lot of them are still under—we have to keep them in a small box,” Tourillon said.

HPQ now focuses on announcing completed contracts rather than early-stage agreements.

 

Governance and Transparency Considerations

Several governance issues emerged that may warrant continued investor attention.

Disclosure Asymmetry

Institutional investors receive detailed IP and licensing documentation via data rooms, while retail shareholders have limited access. Tourillon suggested future Annual Information Forms may expand disclosure.

Valuation Methodology

The absence of an independent valuation introduces uncertainty regarding whether the EUR 30 million figure fully reflects Novacium’s current progress.

Information Blackouts

Third-party restrictions and confidentiality agreements create information gaps that complicate investor assessment of timing and strategic rationale.

Investment Considerations

Positive Elements

  • Capital-efficient structure preserves cash
  • Expanded strategic exposure without losing European funding eligibility
  • Founder incentive alignment
  • Same valuation as 2025 despite technology advancement

Risk Factors

  • 5.2% dilution for equity in a pre-revenue entity
  • Commercialization timelines remain uncertain
  • Internal valuation methodology
  • No direct growth capital injected into Novacium

Critical Dependencies

  • Conversion of technical progress into commercial revenues
  • Market adoption of core platforms
  • Strength of IP protection and licensing
  • HPQ’s ability to monetize North American rights

Conclusion

HPQ Silicon’s increased stake in Novacium represents a calculated bet on near-term commercialization, executed through equity dilution rather than cash deployment.

Management’s thesis rests on technology de-risking, favorable valuation, founder alignment, and a corporate structure that enables more aggressive European growth while preserving HPQ’s economic interests.

For investors, the core question remains whether HPQ has secured advantaged positioning in genuinely valuable platforms—or accepted meaningful dilution for assets that remain speculative. Execution over the coming quarters will determine the outcome.

 

📺 To Watch the Full Video

https://www.youtube.com/playlist?list=PLfL457LW0vdIPGWSIORi4o5U61BVLLsCr

 

AGORACOM Beyond the Mic is powered by AGORACOM’s AI Content Agents.

HPQ Silicon is a client of AGORA Internet Relations Corp.

https://agoracom.com/ir/Agoracomupdates/forums/discussion/topics/796135-DISCLAIMER-AND-DISCLOSURE/messages/2399000 

HPQ’s Bigger Slice of Novacium Is Like Google Buying YouTube For Its Energy Transition Playbook

Posted by Alavaro Coronel at 6:05 PM on Wednesday, February 4th, 2026

When an emerging technology company quietly secures a larger slice of the engine driving its future, it can mark a seismic shift in long-term value creation.

In this case, HPQ Silicon Inc. is lifting its stake in its French partner Novacium SAS by another 8.4 percentage points, taking ownership from 28.4% to 36.8% through an all-share deal valued at:

  • C$4,033,425 / EUR 2.5 million

For a portfolio spanning silicon anode batteries, autonomous hydrogen, and waste-to-value technologies, this higher stake deepens HPQ’s claim on a multi-platform energy-transition business built in Europe.

The valuation is unchanged from HPQ’s 2025 step-up, but the underlying technology set and commercialization visibility are not. And that’s where the leverage lies.

WHAT YOU NEED TO KNOW

  • Stake Jump: HPQ is acquiring 84 additional Novacium shares, raising ownership from 28.4% to 36.8% for C$4,033,425 (EUR 2.5M), at the same implied ~EUR 30M valuation used in February 2025.
  • Share Currency: Consideration is 22,407,916 HPQ common shares at C$0.18, representing roughly 5.2% dilution in exchange for an 8.4% incremental equity stake. All shares are locked up for four months and one day.
  • Platform Power: Novacium’s portfolio spans:
    • Silicon-based anode materials
    • Non-electrolyser autonomous hydrogen generation
    • Circular black-dross-to-value processes
  • 2025 saw patents filed, GEN3 batteries surpass 1,000 cycles, and strategic collaborations initiated.
  • Global Upside: Beyond HPQ’s exclusive North American licenses, the larger equity position increases HPQ’s participation in international revenues and royalty streams tied to Novacium’s technologies.
  • Capital Discipline: The deal is arm’s length, subject to TSX Venture Exchange and regulatory approvals, and preserves HPQ’s cash while maintaining its renewed option framework to further increase ownership over the next four years.

STRATEGIC IMPLICATIONS

For decades, IP-heavy energy-transition platforms have created most of their value in private structures or offshore vehicles, leaving public-market investors with indirect or limited exposure.

Legacy models often:

  • Fragment licensing across regions
  • Misalign founders and partners
  • Force public partners to fund R&D without proportionate ownership

That structure can work when technologies are speculative, but becomes a liability once platforms start to de-risk and commercialization paths come into focus.

Novacium Is Built Differently

Novacium is an IP and execution engine advancing three interlocking pillars:

  1. Silicon anode materials
  2. Autonomous hydrogen systems
  3. Circular waste-to-value processes

All rooted in silicon and battery know-how.

In 2025:

  • GEN3 18650 cells using Novacium’s silicon-based anodes retained 80%+ capacity after 900–1,000 cycles
  • Delivered roughly 30% more cumulative energy versus graphite
  • New patents were filed on:
    • Black-dross processing
    • Advanced cathode materials

HPQ’s move to increase its equity stake at the same ~EUR 30M valuation effectively buys more of that de-risked portfolio at last year’s price.

TIMING MATTERS

As Novacium ramps its brand presence in Europe, pursues non-dilutive EU funding, and engages strategic partners under NDA, the risk grows that outside capital could dilute HPQ’s participation if its stake remained static.

By moving now, and paying in shares instead of cash, HPQ:

  • Secures a stronger economic and governance position
  • Preserves balance-sheet flexibility
  • Maintains momentum across its other pillars, from fumed silica to high-purity silicon

In markets where batteries, hydrogen, and circular processes are converging into multi-billion-dollar verticals, HPQ is tightening its grip on the European engine underpinning much of its future pipeline.

CEO BERNARD TOURILLON

“This isn’t a tactical tweak; it’s a disciplined capital allocation decision. We’re using shares to buy a bigger piece of a platform that’s already de-risking and starting to blossom, without touching our cash. It moves us from just licensing North America to having a much larger claim on value creation across every geography as Novacium’s technologies go to work.”

INVESTOR TAKEAWAY

HPQ is effectively trading 5.2% dilution today for a meaningfully larger stake in an asset whose IP, patents, and early battery and hydrogen results suggest far greater optionality than its unchanged ~EUR 30M valuation implies.

This transaction:

  • Consolidates HPQ’s economic participation in Novacium’s global commercialization
  • Reduces the risk of fragmented IP decisions
  • Preserves cash for core project execution across all pillars

For investors, this looks less like a one-off corporate reshuffle and more like HPQ’s Google-buys-YouTube moment, a deliberate move to own more of the platform that could power its long-term energy-transition growth.

HPQ Silicon’s Commercially Validated Fumed Silica Process Carries Potential for Global Disruption

Posted by Alavaro Coronel at 10:20 AM on Saturday, January 31st, 2026

What You Need To Know

  • Independent third-party validation confirms commercial-grade 150 fumed silica produced at pilot scale
  • Validation performed by a potential customer under an existing Letter of Intent
  • Results support ongoing commercialization discussions, including with the party under LOI
  • Performance metrics, including viscosity, meet or exceed benchmark specifications
  • Planning initiated for a potential dedicated production site as demand visibility improves

Here’s how HPQ Silicon Inc. is positioning its proprietary process as a simplified, lower-barrier alternative with the potential to materially change production economics in a legacy industrial materials market.

A NEW APPROACH TO A LEGACY INDUSTRIAL MATERIAL

Fumed silica is a critical additive used to control thickness and stability in products ranging from toothpaste and cosmetics to adhesives, coatings, inks, and advanced industrial formulations. Despite its broad use, the industry has relied for decades on complex, fossil-fuel-intensive, multi-step manufacturing processes that are costly, environmentally burdensome, and dominated by a small number of global suppliers.

HPQ’s approach is fundamentally different. Its process converts quartz directly into fumed silica in a single step, eliminating several traditional intermediates. The result is a simplified production pathway that has the potential to reduce complexity and materially alter the cost structure associated with fumed silica manufacturing.

WHY INDEPENDENT VERIFICATION MATTERS

While HPQ had previously demonstrated promising lab-scale results, commercialization in industrial materials depends on more than internal testing. Customers must confirm that a product performs within their own application and process requirements.

That hurdle has now been cleared.

Independent testing conducted by a potential customer under LOI confirmed that HPQ’s pilot-scale material meets commercial-grade 150 specifications, including surface area and viscosity—two of the most important performance metrics buyers evaluate.

“Until we had gotten this result, we were making a big claim. Now, we have the data to prove it.”
— Bernard Tourillon, CEO, HPQ Silicon Inc.

FROM TECHNICAL PROOF TO COMMERCIAL DISCUSSIONS

Commercial-grade 150 is not an experimental specification. It is a sellable, widely used product grade in today’s market. Importantly, HPQ’s material demonstrated viscosity performance above standard benchmarks for the 150 grade, a key factor in real-world applications where fumed silica is purchased specifically for its thickening and rheological properties.

With validation in hand, HPQ reports that commercialization discussions have continued in parallel, including dialogue around the steps required to move toward an initial commercial-scale facility. While execution of the first plant remains the primary remaining risk, management emphasized that the most difficult technical transition—moving from lab to pilot scale—has already been completed.

STRATEGIC STRUCTURE AND PARTNERSHIP FOUNDATION

The fumed silica initiative is supported by a joint operating structure with PyroGenesis Inc., combining HPQ’s commercial strategy with PyroGenesis’ engineering and process expertise. This structure is designed to reduce execution risk as the project advances toward continuous operation and commercial-scale deployment.

In addition, the LOI framework under discussion contemplates a model where HPQ focuses on production while its partner leverages established downstream capabilities such as packaging and market access—an approach intended to reduce capital intensity and support a more efficient path to market.

MARKET SCALE AND REPLICATION POTENTIAL

Management highlighted that the Canadian fumed silica market alone is estimated at 10,000–15,000 tonnes per year, with material 150 representing a meaningful portion of that demand. Once an initial commercial system is operational, the pathway to growth becomes largely replicative—scaling by adding additional systems rather than reinventing the process.

Beyond grade 150, HPQ believes its technology can be optimized to produce higher-value grades over time, but the current milestone confirms that commercial entry does not depend on future enhancements.

THE OUTLOOK: A PROCESS MOVING FROM VALIDATION TO EXECUTION

With independent customer validation, a defined commercialization pathway, and early planning for a dedicated production site, HPQ has moved its fumed silica initiative into a new phase. The remaining challenge is execution—building and operating the first commercial system—but the company now approaches that step with verified performance data, active industrial engagement, and a clearer line of sight to market demand.

For investors seeking small-cap opportunities where technical risk has been substantially reduced and commercialization discussions are grounded in disclosed customer validation, this interview captures a moment where HPQ’s fumed silica strategy begins to transition from promise to potential production.

HPQ Silicon Enters a Commercial Transition Year Across Fumed Silica, Batteries, and Hydrogen

Posted by Alavaro Coronel at 1:04 PM on Friday, January 9th, 2026

What You Need To Know

  • Commercial-grade fumed silica achieved at pilot scale, triggering inbound interest
  • New technology demand could push fumed silica beyond existing global capacity
  • UL 1642 cell-level certification opens U.S. battery commercialization pathways
  • Hydrogen is advancing toward defined remote and industrial energy use cases

Here’s how HPQ Silicon is moving from technical validation toward commercial execution across three advancing platforms.

FROM LAB RESULTS TO MARKET PULL

In this wide ranging discussion, Bernard Tourillon joins usto unpack what management describes as a turning point year. After years of development across three advanced material platforms, the conversation makes clear that HPQ is no longer operating in a purely R&D driven phase.

The shift began when HPQ successfully replicated commercial grade fumed silica at pilot scale. That milestone did more than validate the process. It triggered unsolicited outreach from multiple external groups tied to advanced technology infrastructure.

FUMED SILICA MOVES INTO STRATEGIC TERRITORY

Management outlined why fumed silica is increasingly being viewed as a strategic material rather than a niche industrial input. Emerging technology infrastructure requires materials that can withstand higher performance thresholds, and existing supply chains may not be positioned to respond quickly.

Today, roughly half of global fumed silica supply is produced in China. At the same time, traditional producers face long construction timelines, complex permitting, and high energy intensity when adding new capacity.

HPQ’s process takes a different approach by converting quartz directly into fumed silica in a single step. This enables faster permitting, simpler plant construction, and modular expansion once the first commercial facility is built.

The company believes this structural advantage could become increasingly relevant if demand accelerates faster than incumbents can scale.

BATTERY MATERIALS CROSS A COMMERCIAL GATE

On the battery side, HPQ achieved UL 1642 cell level certification, which management repeatedly described as a critical inflection point. Without this certification, customers face barriers related to insurance, transportation, and regulatory compliance.

With certification now in place, discussions can move from technical interest to practical execution.

According to Tourillon, this allows conversations to advance into customer qualification, volume planning, and partnership structures, particularly in the U.S. market. The company is now developing multiple battery iterations tailored to different performance profiles, including applications such as drones and mobility platforms.

Government involvement was also highlighted as a form of validation rather than dependence. Funding is structured to support ongoing scale up as milestones are met, rather than requiring full capital commitment in advance.

HYDROGEN SHIFTS FROM CONCEPT TO USE CASE

While hydrogen remains earlier in its commercialization timeline, management emphasized that its role is becoming more concrete. The technology is designed for decentralized energy environments where diesel remains the default option due to logistics and reliability constraints.

Examples discussed include northern housing developments, mining camps, and remote industrial sites. HPQ’s approach uses recycled aluminum as a stable energy carrier that can be stored indefinitely and activated on demand to produce energy and heat.

Tourillon noted that economics and demand visibility are improving, with expectations that early 2026 will begin to demonstrate clearer commercial validation for this platform.

THE SUM OF THE PARTS QUESTION

One of the most consequential moments in the interview came during a candid discussion about corporate structure. With all three platforms advancing simultaneously, management acknowledged that the current structure may not fully reflect underlying value.

“The reality is that the sum of our parts is bigger than the company.”

Tourillon confirmed that 2026 is likely the year when formal separation processes begin, with fumed silica identified as the most probable first candidate for independence. The company is already structurally prepared for this outcome through existing subsidiaries.

THE INVESTOR TAKEAWAY

This conversation was not about distant promise. It was about technologies that have reached validation, are attracting real world interest, and are now moving into monetization focused execution.

For investors, the key shift is not just progress within each vertical, but management’s willingness to address structure, prioritization, and value realization head on. HPQ is entering a phase where market results, not just technical milestones, are expected to define the next chapter.